AU2002223149A1 - Anticancer agent comprising mycolactone - Google Patents
Anticancer agent comprising mycolactoneInfo
- Publication number
- AU2002223149A1 AU2002223149A1 AU2002223149A AU2314902A AU2002223149A1 AU 2002223149 A1 AU2002223149 A1 AU 2002223149A1 AU 2002223149 A AU2002223149 A AU 2002223149A AU 2314902 A AU2314902 A AU 2314902A AU 2002223149 A1 AU2002223149 A1 AU 2002223149A1
- Authority
- AU
- Australia
- Prior art keywords
- mycolactone
- anticancer agent
- anticancer
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20000070089 | 2000-11-23 | ||
KR0070089 | 2000-11-23 | ||
KR0080184 | 2000-12-22 | ||
KR10-2000-0080184A KR100408916B1 (en) | 2000-11-23 | 2000-12-22 | An anticancer drug comprising a mycolactone, an antisense Rb oligonucleotide that decreases human retinoblastoma protein expression and an anticancer drug comprising a mycolactone and the said antisense Rb oligonucleotide |
PCT/KR2001/002026 WO2002041888A1 (en) | 2000-11-23 | 2001-11-23 | Anticancer agent comprising mycolactone |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002223149A1 true AU2002223149A1 (en) | 2002-06-03 |
Family
ID=26638563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002223149A Abandoned AU2002223149A1 (en) | 2000-11-23 | 2001-11-23 | Anticancer agent comprising mycolactone |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1343496A4 (en) |
AU (1) | AU2002223149A1 (en) |
WO (1) | WO2002041888A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006099667A1 (en) * | 2005-03-21 | 2006-09-28 | The Walter And Eliza Hall Institute Of Medical Research | Prophylactic and therapeutic agents and uses therefor |
CN103667183B (en) * | 2013-11-22 | 2018-06-12 | 南昌艾迪康临床检验所有限公司 | Bone marrow cell cultures |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07250684A (en) * | 1994-03-15 | 1995-10-03 | Chikyu Kankyo Sangyo Gijutsu Kenkyu Kiko | Fragment of nucleic acid and plasmid vector for manifesting the same fragment |
US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
JP2003501423A (en) * | 1999-06-03 | 2003-01-14 | アメリカ合衆国 | Mycolactone and related compounds, compositions, and methods of use |
US6562602B2 (en) * | 2000-08-03 | 2003-05-13 | Kosan Biosciences, Inc. | Fermentation and purification of mycolactones |
-
2001
- 2001-11-23 WO PCT/KR2001/002026 patent/WO2002041888A1/en not_active Application Discontinuation
- 2001-11-23 EP EP01997303A patent/EP1343496A4/en not_active Withdrawn
- 2001-11-23 AU AU2002223149A patent/AU2002223149A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1343496A4 (en) | 2006-03-15 |
EP1343496A1 (en) | 2003-09-17 |
WO2002041888A1 (en) | 2002-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001246876A1 (en) | Remedies | |
AU2001246877A1 (en) | Remedies | |
AU2001262847A1 (en) | Language-understanding | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2002224595A1 (en) | Antitumor agents | |
AU2001288040A1 (en) | Homeostasis-maintaining agents | |
AU2002214284A1 (en) | Anti-helicobacterial agents | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
EP1151667A3 (en) | Plant-activating agent | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2002221099A1 (en) | Combination drugs | |
AU1554301A (en) | Radioprotecting agent | |
AU2001232244A1 (en) | Drug comprising combination | |
AU2001246864A1 (en) | Hypotensors | |
AU2001272718A1 (en) | Medicaments | |
AU2001275696A1 (en) | Therapeutic agent | |
AU2001262711A1 (en) | Cytoprotectors | |
AU2001260192A1 (en) | Glycinamides | |
AU2001226668A1 (en) | Crankshaft-starter-generator | |
AU2002223149A1 (en) | Anticancer agent comprising mycolactone | |
AU2000275584A1 (en) | Anticancer compositions | |
AU2001275014A1 (en) | Imidazoloisoquinolines |